OpenAI’s Bubeck denies trying to cut Anthropic mathematician from credit41m ago 10 of the scariest AI villains in movie history42m ago Maven Robotics wants to steal your robot deployment deal43m ago Agent Security Is Not AI Governance: Why Conflating The Two Is A Risk Enterprises Can't Afford46m ago Positron Valued at $5 Billion in New Funding as Demand for AI Chips Surges53m ago 7 Steps to Become a Forward Deployed Engineer in 20261h ago Ramp eyes $60bn valuation three months after $44bn, Bloomberg reports1h ago D-Matrix Connects Raptor XPUs to NVIDIA AI Factories via NVLink Fusion2h ago Andrew Tulloch, Poster Child for Out-of-Control AI Spending, Reportedly Quits Meta1h ago Mother Horrified When Instagram’s AI Scours Social Media for Invasive Information About Her Young Daughters2h ago Salesforce Unveils Six-Capability Trusted AI Harness for Enterprises2h ago US closes $1.9bn loan to restart the Iowa nuclear plant powering Google2h ago OpenAI Gives US Agencies 50% Off Models, Ending $1 Per Year Deal2h ago 47,000 job listings reveal the engineering roles that AI is creating2h ago

OpenAI’s Bubeck denies trying to cut Anthropic mathematician from credit41m ago 10 of the scariest AI villains in movie history42m ago Maven Robotics wants to steal your robot deployment deal43m ago Agent Security Is Not AI Governance: Why Conflating The Two Is A Risk Enterprises Can't Afford46m ago Positron Valued at $5 Billion in New Funding as Demand for AI Chips Surges53m ago 7 Steps to Become a Forward Deployed Engineer in 20261h ago Ramp eyes $60bn valuation three months after $44bn, Bloomberg reports1h ago D-Matrix Connects Raptor XPUs to NVIDIA AI Factories via NVLink Fusion2h ago Andrew Tulloch, Poster Child for Out-of-Control AI Spending, Reportedly Quits Meta1h ago Mother Horrified When Instagram’s AI Scours Social Media for Invasive Information About Her Young Daughters2h ago Salesforce Unveils Six-Capability Trusted AI Harness for Enterprises2h ago US closes $1.9bn loan to restart the Iowa nuclear plant powering Google2h ago OpenAI Gives US Agencies 50% Off Models, Ending $1 Per Year Deal2h ago 47,000 job listings reveal the engineering roles that AI is creating2h ago

Healthcare Machine Learning4 min reading time

Superluminal Medicines Raises $60M Series B to Advance Obesity Drug

Unite.AIPublished 7 days ago

Superluminal Medicines secured $60M in a Series B round led by BVF Partners to advance its selective MC4R agonist drug for rare genetic obesity into Phase 1 trials by end of 2026. The funding will also expand its GPCR-focused AI-driven drug discovery platform.

#biotechnology #bvf-partners #drug-discovery #mc4r #nvidia #ra-capital-management #superluminal-medicines

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources16h ago

Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI4h ago

Healthcare3 min read

Google’s map of every possible DNA typo could speed up rare disease research

Covered by 3 sources2d ago